Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
polycythemia vera/cefalàlgia
L'enllaç es desa al porta-retalls
Pàgina 1 des de 41 resultats
[Headache caused by polycythemia vera. Classification of a headache under the heading of metabolic disturbances].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
As polycythemia vera is a myeloproliferative syndrome, it is based on an autonomic increase in the proliferation of all hematopoetic cells--mostly of erythropoesis. An increase in blood viscosity induces disturbed microcirculation, resulting in headaches with clinical symptoms. So far, the headache
Cluster-Like Headache Revealing Polycythemia Vera: A Case Report
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Herein, we report on a 44-year-old man who presented with cluster headache (CH)-like pain triggered by polycythemia vera (PV). He had severe unilateral head pain attacks lasting about 30 min not associated with cranial autonomic symptoms. After the exclusion of secondary etiologies, the patient was
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Ruxolitinib was recently approved for the treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea based on data from the RESPONSE studies. This phase 3b, Expanded Treatment Protocol study (NCT02292446) of ruxolitinib for hydroxyurea-resistant/intolerant patients with
Recurrent cerebral venous sinus thrombosis in a young man- A case report of JAK2-negative polycythemia vera.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Polycythemia vera (PV) is a myeloproliferative disorder most commonly associated with JAK2V617F mutation. Cerebral venous sinus thrombosis (CVST) has a wide range of etiologies and PV is one of them. CVST associated with PV has a poor prognosis. Some patients with classical PV lack
Polycythemia vera presenting with bilateral papilledema: a rare case report.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
A 45-year-old male patient presented with gradual onset of headache, vomiting and blurring of vision of 28 days duration. Ophthalmological examination revealed normal anterior segment and pupillary reflex. No abnormality was detected in the vitreous. Optic disc showed features of advanced
Rheological study on vascular occlusion and cellular hyperviscosity syndrome in polycythemia vera.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Whole blood viscosity was determined in 10 patients with polycythemia vera and 129 normal controls using a cone-plate type rotational viscometer at 37 degrees C. Three of the patients with polycythemia vera exhibited vascular occlusions including cerebral and myocardial infarction. The remaining
[Polycythemia vera: clinical aspects and course in 86 patients].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We analyze symptoms, clinical course, and survival time of 86 patients with polycythemia vera treated between 1966 and 1987 at the medical polyclinic of the University Hospital of Zürich. The mean age of disease onset in 40 men and 46 women studied was 59 years. Most commonly the first symptoms were
Partial empty sella in a woman with cerebral venous sinus thrombosis: A rare presentation of polycythaemia rubra vera.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We report the case of a 59 year old woman who presented with a six week history of worsening bifrontal headache. On CT brain the only abnormal finding was a partially empty sella potentially indicative of increased intracranial pressure. MRI found a large cerebral venous sinus thrombosis in the
Polycythemia vera in a 12-year-old girl: a case report.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
A case of a 12-year-old girl presenting with headache and splenomegaly and fulfilling the diagnostic criteria of polycythemia vera is reported. Her peripheral blood values were as follows: hemoglobin 18 g/dL, red blood cells 7,000,000/mm3, while blood cells 22,000/mm, and platelets 1,248,000/mm3.
Polycythemia vera: a comprehensive review and clinical recommendations.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
More than a century has elapsed since the appearance of the modern descriptions of polycythemia vera (PV). During this time, much has been learned regarding disease pathogenesis and PV-associated molecular aberrations. New information has allowed amendments to traditional diagnostic criteria.
Ruxolitinib: a targeted treatment option for patients with polycythemia vera.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm characterized by erythrocytosis and the presence of Janus kinase (JAK) 2V617F or similar mutations. This review summarizes the pathophysiology of PV, the challenges associated with traditional treatment options, and
[Neurologic manifestations of polycythemia vera. Analysis of 24 cases and review of the literature].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Neurological symptoms (NS) of 33 patients diagnosed as suffering from polycythemia vera (PV) are described. 24 of them (73%) had NS at some point in their evolution, the most frequent being related to blood hyperviscosity (headache 51%, dizziness 36%, paresthesias 30%, sight alterations 21%). 5
[Polycythemia vera, clinical aspects and disease course].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The data of 140 patients with polycythemia vera during the period 1955--1975 were analyzed with regard to clinical signs and prognosis. The average age was 53,4 years. The sex ratio was 1.9:1 in favor of men. The most frequent symptoms were headache and vertigo. In more than half of the cases
Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991).
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The 'gold standard' for the treatment of polycythemia vera (PV) is to date undefined. We performed a retrospective analysis to evaluate the outcome of a cohort of PV patients treated with pipobroman (PB) at a single institution during a period of 20 years (November 1971-October 1991). During this
Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The quality of life (QoL) at the time of diagnosis of myeloproliferative neoplasm (MPN) has, to date, not been studied. One hundred and seventy-nine patients with MPN: 80 with essential thrombocythemia (ET), 73 with polycythemia vera (PV), 22 with primary myelofibrosis (PMF) and four with MPN
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
